The impact of knowledge of HPV positivity on cytology triage in primary high-risk HPV screening

被引:7
|
作者
Aitken, Clare A. [1 ]
Holtzer-Goor, Kim M. [2 ]
Uyterlinde, Anne [3 ]
van den Brule, Adriaan J. C. [4 ]
van der Linden, Hans C. [4 ]
Huijsmans, Cornelis J. [4 ]
de Kok, Inge M. C. M. [1 ]
van Kemenade, Folkert J. [5 ]
机构
[1] Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands
[2] Dutch Natl Inst Publ Hlth & Environm, Ctr Populat Screening, Bilthoven, Netherlands
[3] Facilitaire Samenwerking Bevolkingsonderzoeken, Utrecht, Netherlands
[4] Jeroen Bosch Hosp, Pathol DNA, Shertogenbosch, Netherlands
[5] Erasmus MC Univ Med Ctr, Dept Pathol, Rotterdam, Netherlands
关键词
hrHPV screening; cervical cytology; cervical cancer screening;
D O I
10.1177/0969141319864991
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective Several studies have shown that there is an upward shift in the classification of cervical cytology when high-risk human papillomavirus (hrHPV) status is known to be positive. The Netherlands implemented primary hrHPV screening with reflex cytology as the primary screening test in 2017. Prior to implementation of the new programme, we investigated whether knowledge of hrHPV status influences cytology rating. Methods Using a set of 200 cytology slides that had been previously tested, two pairs of cytotechnicians rated 100 slides per pair twice: first without knowledge of hrHPV status and then, after a wash-out period of two months, with knowledge of hrHPV status. Results We found that hrHPV positive slides were more likely to be rated up over the referral threshold (i.e. from negative for intraepithelial lesion or malignancy to atypical squamous cells of undetermined significance+) than hrHPV negative slides at the second review when hrHPV status was known (relative risk = 3.2; 95% confidence interval: 1.3-7.9). Conclusions If the same upward shift in ratings were to be observed in the national programme, it may have implications for referrals of women with low-grade lesions.
引用
收藏
页码:221 / 224
页数:4
相关论文
共 50 条
  • [1] PERFORMANCE OF HIGH-RISK HPV DNA GENOTYPING FOR PRIMARY CERVICAL CANCER SCREENING AND TRIAGE, COMPARED TO CYTOLOGY.
    Chatzistamatiou, K.
    Kaufmann, A. M.
    Jansen-Duerr, P.
    Skenderi, A.
    Angelidou, S.
    Katsiki, E.
    Agorastos, T.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 971 - 971
  • [2] Alternative cytology triage strategies for primary HPV screening
    Vahteristo, Maija
    Heinavaara, Sirpa
    Anttila, Ahti
    Sarkeala, Tytti
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 167 (01) : 73 - 80
  • [3] BUDGET IMPACT ANALYSIS OF NATIONAL CERVICAL CANCER SCREENING PROGRAM IN DENMARK: CYTOLOGY WITH HPV TRIAGE VS. HPV PRIMARY SCREENING WITH REFLEX CYTOLOGY TRIAGE & CINTEC PLUS CYTOLOGY
    Kempers, J.
    Narvestad, J.
    Kofod, M.
    Mikkelsen, R. M.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A689 - A689
  • [4] Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
    Agorastos, Theodoros
    Chatzistamatiou, Kimon
    Katsamagkas, Taxiarchis
    Koliopoulos, George
    Daponte, Alexandros
    Constantinidis, Theocharis
    Constantinidis, Theodoros C.
    [J]. PLOS ONE, 2015, 10 (03):
  • [5] Triage of high-risk HPV positive women in cervical cancer screening
    Ebisch, Renee M. F.
    Siebers, Albert G.
    Bosgraaf, Remko P.
    Massuger, Leon F. A. G.
    Bekkers, Ruud L. M.
    Melchers, Willem J. G.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (10) : 1073 - 1085
  • [6] Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study
    Kimon Chatzistamatiou
    Theodoros Moysiadis
    Eleftherios Angelis
    Andreas Kaufmann
    Alkmini Skenderi
    Pidder Jansen-Duerr
    Irini Lekka
    Vasilis Kilintzis
    Stamatia Angelidou
    Evangelia Katsiki
    Ingke Hagemann
    Athena Tsertanidou
    Isabel Koch
    Oliver Boecher
    Erwin Soutschek
    Nikolaos Maglaveras
    Theodoros Agorastos
    [J]. Archives of Gynecology and Obstetrics, 2017, 295 : 1247 - 1257
  • [7] Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study
    Chatzistamatiou, Kimon
    Moysiadis, Theodoros
    Angelis, Eleftherios
    Kaufmann, Andreas
    Skenderi, Alkmini
    Jansen-Duerr, Pidder
    Lekka, Irini
    Kilintzis, Vasilis
    Angelidou, Stamatia
    Katsiki, Evangelia
    Hagemann, Ingke
    Tsertanidou, Athena
    Koch, Isabel
    Boecher, Oliver
    Soutschek, Erwin
    Maglaveras, Nikolaos
    Agorastos, Theodoros
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2017, 295 (05) : 1247 - 1257
  • [8] Evaluation of HPV-16 and HPV-18 Genotyping for the Triage of Women With High-Risk HPV plus Cytology-Negative Results
    Wright, Thomas C., Jr.
    Stoler, Mark H.
    Sharma, Abha
    Zhang, Guili
    Behrens, Catherine
    Wright, Teresa L.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 136 (04) : 578 - 586
  • [9] Validation of high-risk HPV tests for primary cervical screening
    Meijer, C. J. L. M.
    Berkhof, H.
    Heideman, D. A. M.
    Hesselink, A. T.
    Snijders, P. J. F.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2009, 46 : S1 - S4
  • [10] The impact of HPV triage and test of cure and primary HPV screening on a colposcopy service in England
    Palmer, J.
    [J]. CYTOPATHOLOGY, 2015, 26 (02) : 79 - 82